Apioc Presbyopic Contact Lens

Sponsor
Lentechs, LLC (Industry)
Overall Status
Completed
CT.gov ID
NCT04437732
Collaborator
(none)
49
2
1
18.9
24.5
1.3

Study Details

Study Description

Brief Summary

In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).

Condition or Disease Intervention/Treatment Phase
  • Device: Apioc-P and Apioc-PT Contact Lens Design
N/A

Detailed Description

Apioc-P and Apioc-PT is an investigational contact lens, which means it has not been approved by the U.S. Food and Drug Administration (FDA), although the contact lens material, called Definitive 74, is already approved and marketed for contact lenses that are similar to Apioc-P and Apioc-PT. In this study, participants will wear an Apioc-P and Apioc-PT contact lens the way they wear their current contact lenses for approximately one month (no more than 35 days).

Participation in this study will include a minimum of four study visits. The first will last up to 90 minutes, the second will last up to 45 minutes, the third will last up to 45 minutes, and the final visit will be up to 90 minutes. If the lens does not appear to be fitting properly at the second visit, then another lens will be ordered for participants and they will be asked to return for an additional visit for up to 45 minutes. Up to 60 subjects will participate in this study.

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
30 Day Trial Fitting of a New Bifocal Contact Lens
Actual Study Start Date :
Nov 11, 2019
Actual Primary Completion Date :
Jun 9, 2021
Actual Study Completion Date :
Jun 9, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Apioc Lens

All subjects will wear either the Apioc-P or Apioc-PT contact lens design

Device: Apioc-P and Apioc-PT Contact Lens Design
Novel soft contact lens design

Outcome Measures

Primary Outcome Measures

  1. Visual Acuity [30 days]

    LogMAR visual acuity

Secondary Outcome Measures

  1. Comfort [30 days]

    Contact Lens Dry Eye Questionnaire-8, scale range 0 minimum (better outcome) to 38 maximum (worse outcome).

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. The subject must provide written informed consent.

  2. The subject must appear willing and able to adhere to the instructions set forth in this protocol.

  3. At least 40 years of age and no more than 70 years of age.

  4. ≤ 4.00 D of corneal astigmatism.

  5. ≤ 4.00 D of refractive astigmatism.

  6. Refractive error range +20.00 DS to -20.00 DS

  7. Keratometry readings within 40 to 50D.

  8. Clear, healthy corneas with no irregular astigmatism.

  9. Normal, healthy conjunctiva in both eyes.

  10. Free of active ocular disease. Refractive error and presbyopia are permitted.

  11. Be a current or former (within the last 12 months) contact lens wearer.

  12. Best-corrected near and distance visual acuity better than or equal to 20/25.

Exclusion Criteria:
  1. Irregular corneal astigmatism.

  2. Corneal scarring unless off line-of-site and well healed.

  3. Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear.

  4. Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Use of artificial tears less than 3 times per week is permitted.

  5. Systemic disease that would interfere with contact lens wear.

  6. Currently pregnant or lactating (by self-report).

  7. History of strabismus or eye movement disorder, including exophoria at near that is 4D or greater than at far, and a receded near point of convergence break that is 6 cm or greater.

  8. Active allergies that may inhibit contact lens wear.

  9. Upper eyelid margin at or above the superior limbus.

  10. History of ocular or lid surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Quinn Foster & Associates Athens Ohio United States 45701
2 EyeCare Professionals of Powell Powell Ohio United States 43065

Sponsors and Collaborators

  • Lentechs, LLC

Investigators

  • Principal Investigator: Thomas G Quinn, OD, MS, FAAO, Drs. Quinn, Foster & Associates
  • Principal Investigator: Jason R Miller, OD, MBA, Eyecare Professionals of Powell

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lentechs, LLC
ClinicalTrials.gov Identifier:
NCT04437732
Other Study ID Numbers:
  • LEN-002
First Posted:
Jun 18, 2020
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Lentechs, LLC
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2022